Acknowledgement
Supported by : 가톨릭중앙의료원
References
- Moradpour D, Wands JR. Understanding hepatitis B infection. N Engl J Med 1995;332:1092-3 https://doi.org/10.1056/NEJM199504203321610
- Choung JM, Kim JC, Eun SH, Hwang PH, Nyhambat B, Kilgore P, et al. Study on vaccination state in children: Jeonbuk Province, 2000. J Korean Pediatr Soc 2002;45: 1234-40
- Chang JY, Cheong SJ, Kim SK, Son BK, Hong YJ, Hong KS. Positive rate of HBsAg in school children in Incheon area. Korean J Pediatr Infect Dis 2003;10:153-8 https://doi.org/10.14776/kjpid.2003.10.2.153
- The Office for Health and Medical Care Policy in The Ministry of Health & Welfare, Division of Chronic Disease Surveillance in Korea Centers for Disease Control and Prevention. 2005 National Health and Nutrition Survey in Korea: Medical Examination Survey. Kwacheon: The Ministry of Health & Welfare, 2006:204
- McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of carrier state. J Infect Dis 1985; 151:599-603 https://doi.org/10.1093/infdis/151.4.599
- Andre FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994;44:144- 51 https://doi.org/10.1002/jmv.1890440206
- Kim JH, Kang JH, Oh CK. Immune responses and efficacy of hepatitis B vaccine in neonates born from hepatitis B carrier mothers: focus on HBV-DNA. J Korean Pediatr Soc 1998:41:1498-508
- Milich DR, Jones JE, Hughes JL, Price J, Raney AK, Mclachlan A. Is a function of the secreted hepatitis B eantigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 1990;87:6599-603
- Kim JH, Pyo CW, Koh DK, Hur JK, Kang JH, Kim TG. Alteration of the influences of HLA classes I and II alleles on the perinatal hepatitis B virus infection after immunoprophylaxis in Korean children. Hepatol Res 2006;35:118-26 https://doi.org/10.1016/j.hepres.2006.03.004
- Kim JH, Pyo CW, Hur SS, Kim YK, Kim TG. Influences of IL-1B, IL-1RN, TNFA, and TNFB alleles on chronic HBV infection and perinatal infections of hepatitis B virus after immunoprophylaxis. Human Immunol 2003;64 Suppl 10:143
- Oon CJ, Lim GK, Ye Z, Goh KT, Tan KL, Yo SL, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995;13:699-702 https://doi.org/10.1016/0264-410X(94)00080-7
- Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999;30:1312-7 https://doi.org/10.1002/hep.510300511
- Nainan OV, Khristova ML, Byun K, Xia G, Taylor PE, Stevens CE, et al. Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection. J Med Virol 2002;68:319-27 https://doi.org/10.1002/jmv.10206
- Kim JH, Koh DK, Hur JK, Kang JH, Nainan OV, Margolis HS. The incidence rate of hepatitis B virus surface gene variants in Korean children with immunoprophylaxis failure of perinatal infection. Korean J Hepatol 2005;11:320-8
- Ip HMH, Lelie PN, Wong VCW, Kuhns MC, Reesink HW. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989;i:406-9
- Wheeley SM, Jackson PT, Boxall EH, Tarlow MJ, Gatrad AR, Anderson J, et al. Prevention of perinatal transmission of hepatitis B virus(HBV): a comparison of two prophylactic schedules. J Med Virol 2001;35:212-5 https://doi.org/10.1002/jmv.1890350312
- Lin HH, Chang MH, Chen DS, Sung JL, Hong KH, Young YC, et al. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysisof prophylaxis failure. Vaccine 1991;9:457-60 https://doi.org/10.1016/0264-410X(91)90135-S
- del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WCJ, Gerards LJ, et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997; 15:1624-30
- Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as a risk. Clin Infect Dis 1998;27:100-6 https://doi.org/10.1086/514610
- Zhang SL, Han XB, Yue YF. Relationship between HBV viremia level of pregnant women and intrauterine infection: nested PCR for detection of HBV DNA. World J Gastroenterol 1998;4:61-4
- Wang Z, Zhang J, Yang H, Li X, Wen S, Guo Y, et al. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003;71:360-6 https://doi.org/10.1002/jmv.10493
- van Zonneveld M, van Nunen AB, Niesters HGM, de Man RA, Schalm SW, Janssen HLA. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003;10:294-7 https://doi.org/10.1046/j.1365-2893.2003.00440.x
- Soderstrom A, Norkrans G, Lindh M. Hepatitis B virus DNA during pregnancy and postpartum: aspects on vertical transmission. Scand J Infect Dis 2003;35:814-9 https://doi.org/10.1080/00365540310016547
- Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A, et al. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001;80:63-71 https://doi.org/10.1046/j.1423-0410.2001.00003.x
- Kapke GF, Watson S, Sheffler S, Hunt D, Frederick C. Comparison of the Chiron Quantiplex branched DNA (bDNA) assay and the Abbott Genostics solution hybridization assay for quantification of hepatitis B viral DNA. J Viral Hepat 1997;4:67-75 https://doi.org/10.1046/j.1365-2893.1997.00127.x
- Hwang SH, Kim JH, Kang JH, Hur JK, Lee KY, Lee SH, et al. Follow-up of children with chronic hepatitis B virus infection. Korean J Pediatr Infect Dis 2004;11:73-80 https://doi.org/10.14776/kjpid.2004.11.1.73
- Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Eng J Med 1975;292:771-4 https://doi.org/10.1056/NEJM197504102921503
- Marion SA, Pastore MT, Pi DW, Mathias RG. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol 1994;140:734-46 https://doi.org/10.1093/oxfordjournals.aje.a117321
- Kim JH, Seo K, Kim HM. A comparative study for the outcome of perinatal hepatitis B prophylaxis according to the dosages of hepatitis B immunoglobulin. Seoul : Korea Centers for Disease Control and Prevention, 2006
- Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997;4 Suppl 1:11-20 https://doi.org/10.1111/j.1365-2893.1997.tb00155.x
- Nainan OV, Khristova ML, Byun KS, Xia GL, Taylor PE, Stevens CE, et al. Frequency and significance of hepatitis B virus antibody resistant mutants. Antiviral Ther 2000;5 Suppl 1:30
- Rendi-Wagner P, Shouval D, Genton B, Lurie Y, Rumke H, Boland G, et al. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine. Vaccine 2006;24:2781-9 https://doi.org/10.1016/j.vaccine.2006.01.007
- Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-80 https://doi.org/10.1056/NEJM199411033311801